Clinical Trial Update: TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates a thrombopoietin receptor agonist (TPO-RA) to induce immune tolerance in patients with immune thrombocytopenia and achieve susta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Thrombopoietin receptor agonist (TPO-RA)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: RECRUITING